drugset / Trial / NCT02524288

Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring in Women at Risk for Pregnancy (MK-8342B-061)

NCT02524288

Phase 3 Terminated 1941 enrolled Organon and Co
NaSingle-groupOpen-labelPrevention

Summary

The purpose of this study is to assess the contraceptive efficacy of the Etonogestrel (ENG) + 17β-Estradiol (E2) vaginal ring in women between 18 and 35 years of age based on the number of in-treatment pregnancies as expressed by the Pearl Index (PI). The study will also assess the safety and tolerability of the ENG-E2 vaginal ring.

Timeline

Start
2015-08-31
Primary completion
2016-09-16
Completion
2016-09-16

Drugs

EvaluationDrugModalityDoseRoute
Subject Estradiol Other / unclassified 300 ug Other
Subject Etonogestrel Unknown 125 ug Other

Indications

No indication recorded.